Jubilant Ingrevia financials

Latest results Q2 FY27 · Jul–Sep 2026
Revenue
₹1,394cr+24.4% on Q2 FY26
Net profit
₹111cr+60.4% on Q2 FY26
EBITDA margin
15.2%+3.1 pts on Q2 FY26
EPS
₹7.07+60.7% on Q2 FY26

Quarterly results

Every quarter ›
₹ croreQ2 FY27Q2 FY26Change
Revenue1,3941,121+24.4%
EBITDA212136+56.7%
EBITDA margin15.2%12.1%+3.1 pts
Profit before tax14892.9+59.3%
Net profit11169.5+60.4%
EPS₹7.07₹4.40+60.7%

Over time

Q2 FY27 · Jul–Sep 2026latest
Revenue₹1,394 crNet profit₹111 crNet margin8.0%

Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.

Key numbersby financial year

₹ crore except per share
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
9,543————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
20118885.678.872.7
792792764733397
10,134————
4,9244,3884,1784,1364,773
—+5.0%+1.0%−13.3%—
701567519421547
14.2%12.9%12.4%10.2%11.5%
505392361285425
351278251183308
7.1%6.3%6.0%4.4%6.4%
₹22.19₹17.59₹15.90₹11.58₹19.46
—+10.6%+37.3%−40.5%—
—524508430462
—−299−366−568−481
225225142−138−18.9
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

JUBLINGREA₹604.00

Jubilant Ingrevia Ltd.

· Chemicals
₹ CrorePeersVIDHIINGPARADEEPPCBLFACTOALIGPLPAUSHAKLTDTIRUMALCHMMcap ₹9,543 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————9,542.8
- Cash, Equiv & ST Investments72.778.885.6188.5200.7
+ Total Debt396.7733.0763.8791.8791.8
Enterprise Value————10,133.9
Revenue4,772.74,135.84,177.64,388.14,924.1
Growth %, YoY—-13.3+1.0+5.0—
EBITDA547.1421.1519.1567.0700.7
Margin %11.4610.1812.4312.9214.23
EBIT425.0285.0361.5391.6505.3
Net Income307.5182.9251.2277.9350.6
Margin %6.444.426.016.337.12
EPS, Adj (current shares)19.4611.5815.9017.5922.19
Growth %, YoY—-40.5+37.3+10.6—
Cash from Operations462.5430.0508.1524.3—
Capital Expenditures-481.4-568.4-365.8-299.4—
Free Cash Flow-18.9-138.4142.3224.9224.9
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Jubilant Ingrevia financials and key ratios

Prices at the 30 October 2026 close · figures from the company's filings with NSE

Jubilant Ingrevia (NSE: JUBLINGREA) had a market capitalisation of ₹8,801 crore at the 30 October 2026 close (₹558.40 a share), a PE ratio of 25.1 on the last four quarters' profit and a price-to-book ratio of 2.65. In FY26 its consolidated net profit was ₹278 crore on revenue of ₹4,388 crore; in Q2 FY27 (July–September 2026) it was ₹111 crore, up 60.4% year on year. Its debt-to-equity ratio was 0.27 on 30 September 2026. Promoters held 45.22% of the shares on 30 September 2026.

Share price used
₹558.40 · 30 October 2026 close
Latest balance sheet
30 September 2026
Shareholding pattern
30 September 2026

Jubilant Ingrevia at a glance · consolidated

Market cap
₹8,801 Crat ₹558.40 · 30 Oct close
PE ratio (last 4 quarters)
25.131.7 on FY26 profit
Price to book (PB)
2.65book value ₹210.42 a share
ROE (FY26)
9.2%+0.3 pts vs FY25ROCE 10.4%
Debt to equity
0.27net debt ₹693 Cr
Promoter holding
45.22%unchanged vs 30 Jun 202630 September 2026
Dividend yield
0.90%₹5 a share in 12 months
Net worth
₹3,316 Cr+9.1% vs 30 Sep 202530 September 2026
Free cash flow (FY26)
₹225 Cr+58.0% vs FY25

Questions

What is the Jubilant Ingrevia PE ratio today?

Jubilant Ingrevia's PE ratio is 25.1 at the 30 October 2026 close (₹558.40 a share): a market capitalisation of ₹8,801 crore divided by consolidated net profit of ₹351 crore over the last four quarters (Q3 FY26 to Q2 FY27). On FY26 net profit (₹278 crore) it is 31.7.

Is Jubilant Ingrevia debt free?

No. Jubilant Ingrevia had borrowings of ₹895 crore on 30 September 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.27. Its cash and current investments were ₹202 crore, so its net debt was ₹693 crore.

What is the Jubilant Ingrevia debt to equity ratio?

Jubilant Ingrevia's debt-to-equity ratio was 0.27 on 30 September 2026: borrowings of ₹895 crore against total equity of ₹3,316 crore. A year earlier, on 30 September 2025, it was 0.27.

What is the Jubilant Ingrevia PB ratio (price to book value)?

Jubilant Ingrevia's price-to-book (PB) ratio is 2.65 at the 30 October 2026 close: a market capitalisation of ₹8,801 crore divided by shareholders' equity (book value) of ₹3,316 crore on 30 September 2026. That is a book value of ₹210.42 per share against a share price of ₹558.40.

What is the Jubilant Ingrevia net worth?

Jubilant Ingrevia's net worth — shareholders' equity in its consolidated balance sheet — was ₹3,316 crore on 30 September 2026, up 9.1% from ₹3,041 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹8,801 crore at the 30 October 2026 close.

What is the Jubilant Ingrevia ROE and ROCE?

In FY26, Jubilant Ingrevia's return on equity (ROE) was 9.2% and its return on capital employed (ROCE) was 10.4%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 8.9% and ROCE 10.2%.

What is the Jubilant Ingrevia market cap?

Jubilant Ingrevia's market capitalisation was ₹8,801 crore at the 30 October 2026 close: 15.76 crore shares at ₹558.40 each.

What is the Jubilant Ingrevia EPS?

Jubilant Ingrevia's basic earnings per share (EPS) were ₹17.59 in FY26, against ₹15.89 in FY25. Over the last four quarters (Q3 FY26 to Q2 FY27) they add up to ₹22.21.

What is the Jubilant Ingrevia dividend yield?

Jubilant Ingrevia's dividend yield is 0.90% at the 30 October 2026 close: dividends of ₹5 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹558.40. They were ₹2.50 on 24 July 2026 and ₹2.50 on 10 February 2026 (interim).

What is the Jubilant Ingrevia book value per share?

Jubilant Ingrevia's book value per share was ₹210.42 on 30 September 2026: shareholders' equity of ₹3,316 crore divided by the 15.76 crore shares in issue, up 9.3% from ₹192.60 a year earlier. The share price at the 30 October 2026 close was ₹558.40.

What is the Jubilant Ingrevia dividend in 2026 and its record date?

In 2026, Jubilant Ingrevia has declared two dividends totalling ₹5 a share: ₹2.50 (interim) with record date 10 February 2026 and ₹2.50 with record date 24 July 2026.

What is the Jubilant Ingrevia revenue and profit in FY26?

In FY26 (April 2025–March 2026), Jubilant Ingrevia's consolidated net profit was ₹278 crore, up 10.6% from ₹251 crore in FY25, on revenue from operations of ₹4,388 crore (up 5.0%). Over three years, from FY23, net profit was down 9.6%.

What is the Jubilant Ingrevia promoter holding?

Promoters held 45.22% of Jubilant Ingrevia on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.

What is the Jubilant Ingrevia free cash flow?

In FY26, Jubilant Ingrevia generated ₹524 crore of cash from operations and spent ₹299 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹225 crore. In FY25 it was ₹142 crore.

What are the Jubilant Ingrevia latest quarterly results?

Jubilant Ingrevia's latest results are for Q2 FY27 (July–September 2026): consolidated net profit ₹111 crore, up 60.4% from ₹69.5 crore in Q2 FY26; revenue from operations ₹1,394 crore, up 24.4% year on year.

What is the Jubilant Ingrevia shareholding pattern?

On 30 September 2026, Jubilant Ingrevia's shares were held by promoters 45.22%, foreign portfolio investors (FII/FPI) 6.94%, domestic institutions (DII) 25.17% (including mutual funds at 22.59%) and retail and other non-institutional investors 21.69%. Over the year, FII holding was up 0.98 percentage points from 5.96% and DII holding was up 2.13 percentage points from 23.04%.

When are the Jubilant Ingrevia next results?

Jubilant Ingrevia has reported Q2 FY27. Its next results, for Q3 FY27 (October–December 2026), are due by 14 February 2027 under SEBI's 45-day rule; the company notifies the board-meeting date at least two working days before.

How does the Jubilant Ingrevia PE ratio compare with its peers?

At the 30 October 2026 closing prices, on FY26 net profit, Jubilant Ingrevia's PE ratio is 31.7, the second highest of the four: Vidhi Specialty Food Ingredients 31.4, Paradeep Phosphates 13.5 and PCBL Chemical 55.1, a peer average of 33.3. Each is the company's market capitalisation at that price divided by its FY26 net profit.

How does Jubilant Ingrevia compare with its peers?

On FY26 consolidated figures, against Vidhi Specialty Food Ingredients, Paradeep Phosphates and PCBL Chemical: Jubilant Ingrevia's operating margin of 8.9% is the second highest of the four (Vidhi Specialty Food Ingredients 18.1%, Paradeep Phosphates 8.0%, PCBL Chemical 8.2%; peer average 11.4%); its return on equity of 9.2% is the third highest of the four (Vidhi Specialty Food Ingredients 15.6%, Paradeep Phosphates 18.4%, PCBL Chemical 5.1%; peer average 13.0%); its revenue growth over three years of −2.8% a year is the lowest of the four (Vidhi Specialty Food Ingredients −2.0% a year, Paradeep Phosphates 17.8% a year, PCBL Chemical 12.4% a year; peer average 9.4% a year).

Jubilant Ingrevia vs Vidhi Specialty Food Ingredients: how do they compare?

In FY26, Jubilant Ingrevia earned net profit of ₹278 crore on revenue of ₹4,388 crore, against ₹49 crore on ₹380 crore for Vidhi Specialty Food Ingredients. Jubilant Ingrevia's operating margin was 8.9% (Vidhi Specialty Food Ingredients 18.1%) and its return on equity 9.2% (Vidhi Specialty Food Ingredients 15.6%). At the 30 October 2026 close, Jubilant Ingrevia's market capitalisation was ₹8,801 crore against ₹1,538 crore for Vidhi Specialty Food Ingredients, and its PE ratio on FY26 profit 31.7 against 31.4.

Where do these Jubilant Ingrevia figures come from?

From Jubilant Ingrevia's own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 30 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.

Consolidated figures from the company's filings with NSE; prices are NSE closing prices.